Association of transfusion independence with improved overall survival in myelofibrosis patients receiving momelotinib.

Authors

Ruben Mesa

Ruben A. Mesa

UT Health San Antonio, San Antonio, TX

Ruben A. Mesa , Stephen T. Oh , Aaron Thomas Gerds , Vikas Gupta , John V. Catalano , Francisco Cervantes , Timothy Devos , Marek Hus , Jean-Jacques Kiladjian , Ewa Lech-Maranda , Donal P. Mclornan , Jeanne Palmer , Uwe Platzbecker , Jacek Treliński , Kazuya Shimoda , Rafe Donahue , Bryan Strouse , Mark Marion Kowalski , Srdan Verstovsek

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders

Clinical Trial Registration Number

NCT01969838

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 7046)

DOI

10.1200/JCO.2021.39.15_suppl.7046

Abstract #

7046

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Lucia Masarova

First Author: Aaron Thomas Gerds

First Author: Yi Zhang